• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, June 29, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Rheumatology community applauds CMS’s decision to scrap Part B payment demo

Bioengineer by Bioengineer
December 16, 2016
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ATLANTA – – The American College of Rheumatology (ACR) today applauded the decision from the Centers for Medicare & Medicaid Services (CMS) not to go forward with the agency's controversial Part B payment proposal, noting that the hard-fought outcome is good news for rheumatology patients who rely on Medicare Part B to access life-saving biologic therapies.

"We thank CMS for listening to the rheumatology community's concerns about the negative and disproportionate impact this proposal would have on our Medicare patients living with rheumatic diseases by not moving forward with this Part B Demonstration Project," said Dr. Sharad Lakhanpal, MBBS, MD, President of the ACR. "For older Americans living with painful and debilitating diseases like rheumatoid arthritis, lupus, spondyloarthritis, and psoriatic arthritis, safe access to biologic therapies is not an option but a necessity – which is why the ACR has been vocal in expressing our concerns about the unintended consequences of this proposal and its flawed cost-savings premise. This positive outcome will help ensure Medicare beneficiaries living with rheumatic diseases are able to continue receiving the therapies they need to manage their chronic conditions and avoid pain and disability."

From the time it was proposed in March 2016, the ACR has voiced strong opposition to the proposed rule. In detailed comments submitted to CMS earlier this year, the ACR expressed concerns about the lack of less expensive yet clinically equivalent biologic therapy options in the marketplace for Medicare patients living with rheumatic diseases, as well as the safety and health dangers posed by switching from a biologic therapy that works well for the patient.

The ACR has also noted that many rheumatologists – particularly small or rural practices that lack the ability to negotiate bulk discounts with pharmaceutical companies – have already been forced to stop administering biologic therapies to Medicare patients because the current Part B payment structure does not cover the costs of obtaining and providing these complex therapies in the outpatient setting. If the additional payment cuts proposed by CMS in the Part B Demonstration Project were to go through, the ACR warned that many rheumatology patients would be forced into less safe or more expensive settings to receive needed therapies, if these patients were able to receive them at all.

More than 52.5 million people – one in five Americans – live with rheumatic diseases, according to the Centers for Disease Control and Prevention (CDC). Rheumatic diseases are the nation's leading cause of disability, contributing more than $128 billion in costs to the U.S. healthcare system each year.

###

The American College of Rheumatology provides education, research, advocacy and practice management support to more than 6,400 U.S. rheumatologists and rheumatology health professionals. In doing so, the ACR advocates for high-value, high-quality healthcare policies and reforms that will ensure safe, effective, affordable and accessible rheumatology care. For more information, visit http://www.rheumatology.org.

Media Contact

Jocelyn Givens
[email protected]
229-220-6524
@ACRheum

http://www.rheumatology.org

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Berkeley Surface Emitting Laser

New single-mode semiconductor laser delivers power with scalability

June 29, 2022
Studying chemicals in wastewater

Monitoring COVID-19: Could medicine found in wastewater provide an early warning?

June 29, 2022

Ice Age wolf DNA reveals dogs trace ancestry to two separate wolf populations

June 29, 2022

Destruction and recovery of kelp forests driven by changes in sea urchin behavior

June 29, 2022
Please login to join discussion

POPULAR NEWS

  • Pacific whiting

    Oregon State University research finds evidence to suggest Pacific whiting skin has anti-aging properties that prevent wrinkles

    37 shares
    Share 15 Tweet 9
  • University of Miami Rosenstiel School selected for National ‘Reefense’ Initiative focusing on Florida and the Caribbean

    35 shares
    Share 14 Tweet 9
  • Saving the Mekong delta from drowning

    37 shares
    Share 15 Tweet 9
  • Sharks may be closer to the city than you think, new study finds

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

WeaponryUrogenital SystemVaccineZoology/Veterinary ScienceWeather/StormsVirusUrbanizationUniversity of WashingtonVaccinesVirologyVehiclesViolence/Criminals

Recent Posts

  • New single-mode semiconductor laser delivers power with scalability
  • Monitoring COVID-19: Could medicine found in wastewater provide an early warning?
  • Ice Age wolf DNA reveals dogs trace ancestry to two separate wolf populations
  • Destruction and recovery of kelp forests driven by changes in sea urchin behavior
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....